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Recently, Time magazine published an article titled “The Year in 
Medicine: From A to Z” (Park et al. 2008). The letter “B” was repre-
sented by the controversy over bisphenol A, a ubiquitous chemical used 
in polycarbonate and polyvinyl chloride plastics and epoxy resins and 
found in the urine of > 90% of Americans. The debate over whether 
bisphenol A poses a threat to human health has been brewing for the 
better part of the past decade.  
On 3 September 2008, the National Toxicology Program (NTP) 
Center for the Evaluation of Risks to Human Reproduction (CERHR) 
weighed in by releasing a report that significantly contributes to this 
ongoing discussion. The NTP-CERHR Monograph on the Potential 
Human Reproductive and Developmental Effects of Bisphenol A (NTP 
2008a) identified evidence from experimental animal studies that 
raised “some concern” that current levels of exposure to human fetuses, 
infants, and children may result in develop  mental changes in the pros-
tate gland and brain and diminish sexually dimorphic behaviors. “Some 
concern” represents the mid-point of a five-level scale of concern used 
by the NTP that ranges from “negligible” to “serious” concern. A lower 
level, “minimal concern,” was also expressed for possible changes in 
development of the mammary gland and an earlier age of attaining 
puberty in females.
The NTP’s opinion on the level of concern for effects of bisphe-
nol A on human reproduction and development stemmed from a 
2-year analysis of a very limited number of available human studies 
but nearly 1,000 studies in experimental animals. Many of the labora-
tory studies explored effects on offspring of pregnant rodents receiving 
“low doses” of bisphenol A (< 5 mg/kg body weight/day, and includ-
ing studies performed with much lower doses) during critical periods 
of development. The NTP Board of Scientific Counselors (2008) 
provided peer review and suggestions for refinement of the NTP 
CERHR’s conclusions (NTP 2008a), and the Science Board to the 
Food and Drug Administration (FDA 2008a, 2008b) also expressed 
agreement with the evaluation.
The NTP’s evaluation of bisphenol A expressed “some concern” 
because many of the developmental effects reported in laboratory 
animals were observed at exposures to bisphenol A similar to those 
experienced by humans. Collectively, the findings could not be   
dismissed. Similar conclusions were reached by Health Canada (2008) 
and by participants at a workshop examining the potential relationship 
between bisphenol A and negative trends in human health (vom Saal 
et al. 2007). However, the NTP CERHR report (NTP 2008a), as well 
as other reviews, identified many areas of uncertainty and data gaps 
that should be addressed to fully understand bis  phenol A’s potential to 
harm human development. 
In the months since release of the NTP-CERHR report (NTP 
2008a), the literature on exposures and potential human health effects 
of bisphenol A has continued to grow (Calafat et al. 2008; Hugo et al. 
2008; Lang et al. 2008; Leranth et al. 2008), raising public concern and 
generating more questions. Lists of research needs have been assembled 
(NTP 2008a; vom Saal et al. 2007). The NTP and the National 
Institute of Environmental Health Sciences (NIEHS) Division of 
Extramural Research and Training (DERT) recently issued a request 
for information (RFI) to the scientific community seeking information 
to help focus future research and testing activities (NTP 2008b). The 
RFI seeks information about a) on  going research on the health effects 
of bisphenol A; b) unmet research needs; and 
c) suggestions for collabo  ration and coop-
eration between investigators to improve 
efficiency and timeliness in filling the infor-
mation gaps. Together, the NTP and DERT 
will carefully consider the responses to this 
RFI as we develop research programs and 
explore other ways to address these issues in 
the future.
The RFI (NTP 2008b) listed a number of general topics that sci-
entists have consistently raised as areas where research is needed: a) the 
need to better understand sources of human exposures; b) the need to 
compare the metabolism of bisphenol A among rodents, non  human 
primates, and humans and understand how it changes with age; c) the 
need for physiologically based pharmaco  kinetic (PBPK) models to pro-
vide a scaffold for quantitatively assessing the consistency of outcomes 
across studies performed with widely different doses and designs; and 
d) the need for additional developmental toxicology studies of tradi-
tional design and power, but with modifications to provide the capabil-
ity to detect the range of effects reported in academic studies as well as 
functional consequences as the animals age. 
The NTP has begun work in several areas. In collaboration with 
the Centers for Disease Control and Prevention and academic inves-
tigators, we are facilitating an evaluation of exposures to bisphenol A 
in infants in neonatal care settings and in children < 6 years of age. 
Together with the FDA National Center for Toxicological Research, 
we have initiated studies to obtain the data for constructing PBPK 
models in rodents and non  human primates, and we are planning 
studies to explore the long-term consequences of peri  natal exposure to 
bisphenol A in order to understand the potential impact to humans of 
the developmental changes reported in numerous laboratory animal 
studies. The NTP and DERT are considering a number of strategies 
to provide the academic community access to the animals and tissues 
generated in these studies. We will provide additional details on the 
status and direction of our bisphenol A testing program through pub-
lic meetings of the NTP Board of Scientific Counselors. 
Collectively, the results of these studies should begin to chip away at 
the uncertainties and research gaps and provide a better perspective of 
the potential threat that exposure to bisphenol A poses to public health.
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